GOLDENWELL BIOTECH, INC. (GWLL) Operating cash flow 2019–2025
GOLDENWELL BIOTECH, INC. (GWLL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$22,629FY2025 · since FY2019: -$2,311 → -$22,629
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22,629 | +81.6% |
| FY2024 | -$123,077 | -8.8% |
| FY2023 | -$113,153 | +89.5% |
| FY2022 | -$1.1M | -422.8% |
| FY2021 | -$205,138 | -3143.8% |
| FY2020 | -$6,324 | -173.6% |
| FY2019 | -$2,311 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GWLL financial trends
GWLL RevenueGWLL Net incomeGWLL Net marginGWLL Gross profitGWLL Gross marginGWLL Operating incomeGWLL Operating marginGWLL Free cash flowGWLL Capital expendituresGWLL Return on equityGWLL Stock buybacksGWLL Dividends paidGWLL Total assetsGWLL Total liabilitiesGWLL Shareholders’ equityGWLL overview →